Shares of Elevance Health (ELV) are moving lower after the company presented at the Wells Fargo Healthcare Conference. Management said regarding its Medicaid, “Our operating margin performance is expected to be softer than the outlook that we provided in July. We no longer expect sequential operating margin improvement in the second half of the year.” The company added, “We do expect the misalignment of rates with acuity to persist in the near term.” Shares of Elevance Health are down 3% to $311.76 in morning trading.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Elevance Health Reaffirms 2025 Earnings Guidance
- Elevance Health price target raised to $373 from $327 at Barclays
- ACA Rule Pause Offers Relief to UnitedHealth (UNH) and Peers Facing Rising Costs
- Here’s Why UnitedHealth (UNH) and Elevance Health (ELV) Are Exiting Colorado’s ACA Market
- Judges reject 2 cases challenging Medicare negotiation, The Hill reports